Sangamo Therapeutics
SGMO
#10549
Rank
โ‚น2.84 B
Marketcap
โ‚น6.86
Share price
0.00%
Change (1 day)
-80.13%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -โ‚น9.92 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are โ‚น34.55 Million. In 2025 the company made an earning of -โ‚น10.01 Billion a decrease over its 2024 earnings that were of -โ‚น9.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น9.92 Billion-0.92%
2025 -โ‚น10.01 Billion9.71%
2024 -โ‚น9.13 Billion-17.27%
2023 -โ‚น11.03 Billion-40.88%
2022 -โ‚น18.66 Billion9.79%
2021 -โ‚น16.99 Billion41.52%
2020 -โ‚น12.01 Billion23.17%
2019 -โ‚น9.75 Billion36.33%
2018 -โ‚น7.15 Billion36.89%
2017 -โ‚น5.23 Billion-22.32%
2016 -โ‚น6.73 Billion54.86%
2015 -โ‚น4.35 Billion75.62%
2014 -โ‚น2.48 Billion0.13%
2013 -โ‚น2.47 Billion
2011 -โ‚น3.32 Billion43.66%
2010 -โ‚น2.32 Billion28.52%
2009 -โ‚น1.8 Billion-23.55%
2008 -โ‚น2.36 Billion2.45%
2007 -โ‚น2.3 Billion19.5%
2006 -โ‚น1.93 Billion50.78%
2005 -โ‚น1.28 Billion75%
2004 -โ‚น0.73 Billion-33.25%
2003 -โ‚น1.1 Billion-62.27%
2002 -โ‚น2.9 Billion102.82%
2001 -โ‚น1.43 Billion23.21%
2000 -โ‚น1.16 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น1.734 T-17,069.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1.024 T-10,117.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น41.24 B-503.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-โ‚น39.39 Billion 285.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-โ‚น234.74 Billion 2,196.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น623.02 B-6,193.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น113.19 B-1,207.17%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น4.04 B-139.58%๐Ÿ‡บ๐Ÿ‡ธ USA